Morgan Stanley analyst Michael Cyprys downgraded Charles Schwab to Equal Weight from Overweight with a price target of $68, down from $99. The stock is down down 30% month-to-date, but there remains "limited visibility on multiple variables," the analyst tells investors in a research note. The firm says Schwab’s investment thesis has been pushed out and that it has less confidence around the timing of an improvement.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on SCHW: